Browse Studies — Arctuva

Phase 2

MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

This phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating head and neck cance…

Metastatic Oral Cavity CarcinomaRecurrent Oral Cavity CarcinomaStage IVC Lip and Oral Cavity Cancer AJCC v8+15 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06997068

Phase 1

Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer

The goal of this clinical trial is to assess the safety and tolerability of a virus replicon particle (VRP) encapsulated saRNA encoding IL-12 when injected int…

Head and Neck Cancers- Squamous CellHead and Neck CancerSolid Tumors+10 more

Estimated

~$10 – $8,750

VLP TherapeuticsNCT06736379

Observational

Dissecting the Role of Acetaldehyde in Oral Carcinogenesis

This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primar…

Alcohol-Related CarcinomaFanconi AnemiaOral Cavity Carcinoma

Estimated

~$10 – $6,250

Masonic Cancer Center, University of MinnesotaNCT05973656

Phase 2

A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents

This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy…

Head and Neck CarcinomaMalignant Parotid Gland NeoplasmMaxillary Sinus Carcinoma+4 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04870762